JP2002519391A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002519391A5 JP2002519391A5 JP2000557861A JP2000557861A JP2002519391A5 JP 2002519391 A5 JP2002519391 A5 JP 2002519391A5 JP 2000557861 A JP2000557861 A JP 2000557861A JP 2000557861 A JP2000557861 A JP 2000557861A JP 2002519391 A5 JP2002519391 A5 JP 2002519391A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- pkcε
- isoenzyme
- protein kinase
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9175598P | 1998-07-06 | 1998-07-06 | |
| US60/091,755 | 1998-07-06 | ||
| US10376398P | 1998-10-09 | 1998-10-09 | |
| US60/103,763 | 1998-10-09 | ||
| PCT/US1999/015265 WO2000001415A2 (en) | 1998-07-06 | 1999-07-06 | Use of inhibitors of protein kinase c epsilon to treat pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002519391A JP2002519391A (ja) | 2002-07-02 |
| JP2002519391A5 true JP2002519391A5 (https=) | 2005-06-02 |
Family
ID=26784298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000557861A Pending JP2002519391A (ja) | 1998-07-06 | 1999-07-06 | 痛みを処置するための、プロテインキナーゼｃイプシロンの阻害剤の使用 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1093379B1 (https=) |
| JP (1) | JP2002519391A (https=) |
| AT (1) | ATE350032T1 (https=) |
| AU (1) | AU764760B2 (https=) |
| CA (1) | CA2336709A1 (https=) |
| DE (1) | DE69934689T2 (https=) |
| ES (1) | ES2283120T3 (https=) |
| IL (1) | IL140716A0 (https=) |
| NZ (1) | NZ508767A (https=) |
| WO (1) | WO2000001415A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7790192B2 (en) | 1998-08-14 | 2010-09-07 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
| AU2003234185C1 (en) | 2002-04-22 | 2009-11-19 | The Board Of Trustees Of The Leland Stanford Junior University | Peptide inhibitors of protein kinase C |
| US6933275B2 (en) | 2002-05-01 | 2005-08-23 | The Board Of Trustees Of The Leland Stanford Junior University | Protein kinase C peptides for use in withdrawal |
| WO2004084889A1 (en) * | 2003-03-28 | 2004-10-07 | Pfizer Inc. | Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons |
| EP1631309A4 (en) * | 2003-05-16 | 2010-04-28 | Univ Leland Stanford Junior | Protein kinase c peptides for use in withdrawal |
| EP1670497A4 (en) | 2003-09-16 | 2009-07-15 | Garvan Inst Med Res | METHOD FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C EPSILON (PKC Ε) AND METHOD FOR TREATING THEREOF CONVERTING DERIVED GLUCOSE METABOLISM |
| WO2006095086A2 (fr) * | 2005-03-07 | 2006-09-14 | Laurence Faure | Traçabilite des anomalies du cycle cellulaire ciblant l'oncologie et la neurodegenerescence. |
| EP1869205B1 (en) * | 2005-04-02 | 2010-07-14 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | Assays for determining compounds which modulate tram phosphorylation |
| US8575307B2 (en) | 2005-06-29 | 2013-11-05 | Hadasit Medical Research Services & Development Ltd. | Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
| EP2177510A1 (en) | 2008-10-17 | 2010-04-21 | Universität des Saarlandes | Allosteric protein kinase modulators |
| JP2010090176A (ja) * | 2010-01-26 | 2010-04-22 | Board Of Trustees Of The Leland Stanford Junior Univ | 離脱症状における使用のためのプロテインキナーゼｃペプチド |
| US8785648B1 (en) | 2010-08-10 | 2014-07-22 | The Regents Of The University Of California | PKC-epsilon inhibitors |
| WO2014081029A1 (ja) * | 2012-11-26 | 2014-05-30 | 学校法人近畿大学 | 抗がん剤による末梢神経障害の予防、治療、または軽減剤 |
| EP3180003B1 (en) | 2014-07-01 | 2022-01-12 | The Regents of the University of California | Pkc-epsilon inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5141957A (en) * | 1990-11-02 | 1992-08-25 | Sphinx Pharmaceuticals Corporation | 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| US5783405A (en) * | 1994-02-01 | 1998-07-21 | Terrapin Technologies, Inc. | Rapid screening method for effectors of signal transduction |
| WO1997015575A1 (en) * | 1995-10-27 | 1997-05-01 | Procyon Pharmaceuticals, Inc. | Protein kinase c modulators. y. |
-
1999
- 1999-07-06 EP EP99932296A patent/EP1093379B1/en not_active Expired - Lifetime
- 1999-07-06 DE DE69934689T patent/DE69934689T2/de not_active Expired - Lifetime
- 1999-07-06 IL IL14071699A patent/IL140716A0/xx unknown
- 1999-07-06 AT AT99932296T patent/ATE350032T1/de not_active IP Right Cessation
- 1999-07-06 CA CA002336709A patent/CA2336709A1/en not_active Abandoned
- 1999-07-06 ES ES99932296T patent/ES2283120T3/es not_active Expired - Lifetime
- 1999-07-06 NZ NZ508767A patent/NZ508767A/en not_active IP Right Cessation
- 1999-07-06 JP JP2000557861A patent/JP2002519391A/ja active Pending
- 1999-07-06 AU AU48631/99A patent/AU764760B2/en not_active Ceased
- 1999-07-06 WO PCT/US1999/015265 patent/WO2000001415A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002519391A5 (https=) | ||
| Blanchet et al. | Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients | |
| Tamminga et al. | Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains | |
| McCormack et al. | Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: a survey of their analgesic efficacy | |
| Garrido et al. | Gonyautoxin: new treatment for healing acute and chronic anal fissures | |
| CN1440283A (zh) | 有机化合物的联合形式 | |
| CA2652559A1 (en) | Biotherapeutic compositions and uses thereof | |
| BR9612423A (pt) | Composto, composição farmacêutica, e, processo para tratar um estado doentio. | |
| EP3630103A1 (en) | Combined therapy for nmdar antagonist-responsive neuropsychiatric disorders | |
| Iskit et al. | The effects of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice | |
| US6281222B1 (en) | Compositions and method for treatment of acetaminophen intoxication | |
| WO2004050025A3 (en) | Combination of ibuprofen and oxycodone for acute pain relief | |
| KR20010101492A (ko) | 멜라가트란의 신규 용도 | |
| RU2095064C1 (ru) | Средство для снижения агрегации тромбоцитов в кровеносной системе | |
| CN1337879A (zh) | 血管紧张素ii受体拮抗剂在治疗急性心肌梗塞中的应用 | |
| US8642639B2 (en) | Formulation for L-tryptophane comprising carbidopa/benserazide | |
| CA2136205A1 (en) | Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension | |
| Akat et al. | Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension | |
| Kiersch et al. | The onset of action and the analgesic efficacy of Saridon®*(a propyphenazone/paracetamol/caffeine combination) in comparison with paracetamol, ibuprofen, aspirin and placebo (pooled statistical analysis) | |
| US5849774A (en) | Treatment of sepsis-induced acute renal failure | |
| US5216019A (en) | Pain killer | |
| JPWO2005089743A1 (ja) | 腎性貧血治療剤 | |
| CN100409850C (zh) | 2h-[1,3]-噁嗪并[3,2-a]吲哚衍生物在制备治疗神经性疼痛的药物中的用途 | |
| AU2003248555A1 (en) | Anti-cancer formulation | |
| EA007732B1 (ru) | Фармацевтическая комбинация для лечения мышечной спастичности и/или боли |